Clinical trial
A Multicenter, Double-blinded, Randomized, Placebo-controlled Trial to Compare the Effectiveness of Intratympanic Injections methylPREDnisolon Versus Placebo in the Treatment of Vertigo Attacks in MENière's Disease (PREDMEN Trial).
NCT05851508 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Double-blinded, Randomized, Placebo-controlled Trial to Compare the Effectiveness of Intratympanic Injections methylPREDnisolon Versus Placebo in the Treatment of Vertigo Attacks in MENière's Disease (PREDMEN Trial).
- Lead sponsor
- Leiden University Medical Center
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- October 1, 2023
- Completion date
- February 1, 2027
- Enrollment
- 148 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.